Biomedical signals and machine learning in amyotrophic lateral sclerosis: a systematic review

Abstract

Introduction The use of machine learning (ML) techniques in healthcare encompasses an emerging concept that envisages vast contributions to the tackling of rare diseases. In this scenario, amyotrophic lateral sclerosis (ALS) involves complexities that are yet not demystified. In ALS, the biomedical signals present themselves as potential biomarkers that, when used in tandem with smart algorithms, can be useful to applications within the context of the disease. Methods This Systematic Literature Review (SLR) consists of searching for and investigating primary studies that use ML techniques and biomedical signals related to ALS. Following the definition and execution of the SLR protocol, 18 articles met the inclusion, exclusion, and quality assessment criteria, and answered the SLR research questions. Discussions Based on the results, we identified three classes of ML applications combined with biomedical signals in the context of ALS: diagnosis (72.22%), communication (22.22%), and survival prediction (5.56%). Conclusions Distinct algorithmic models and biomedical signals have been reported and present promising approaches, regardless of their classes. In summary, this SLR provides an overview of the primary studies analyzed as well as directions for the construction and evolution of technology-based research within the scope of ALS.

Electronic health records in Brazil: Prospects and technological challenges

“…And this issue is compounded by situations in which patients needing multidisciplinary monitoring have their information collated by several practitioners. Hence, monitoring disease courses becomes even more detrimental ( 32 , 33 ).…”

Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases

“…A novel approach using induced iPSC derived from patients with ALS has opened opportunities to study ALS in vitro as reviewed elseqhere (112). Integration of multimodal data with machine learning has also a potential to change paradigms in the ALS pathway discovery (113). Furthermore, the omics field presents numerous advantages at identifying pathological networks in comparison with other disciplines.…”

Machine learning as a control strategy for smart upper limb orthosis: a scoping review

“…Traditional orthoses have limitations in providing individualized assistance to patients for effective functional rehabilitation [1]. Over the past decade, machine learning (ML) algorithms have emerged as a promising solution to address these limitations [2], supporting health professionals with decision-making, constituting strategies and measures adopted in the care of patients [3][4][5], and for assistive technologies (AT), such as orthosis [2].…”